Watching Shares Of Edgewise Therapeutics; Traders Circulating Undated Report; Edgewise Therapeutics Launches CIRRUS-HCM Trial To Assess Safety And Effects Of EDG-7500, A Novel Cardiac Sarcomere Modulator For Hypertrophic Cardiomyopathy
Watching Shares Of Edgewise Therapeutics; Traders Circulating Undated Report; Edgewise Therapeutics Launches CIRRUS-HCM Trial To Assess Safety And Effects Of EDG-7500, A Novel Cardiac Sarcomere Modulator For Hypertrophic Cardiomyopathy
關注Edgewise Therapeutics股票;交易員傳閱未標明日期的報告;Edgewise Therapeutics推出CIRRUS-HCm試驗,評估EDG-7500的安全性和效果,這是一種新型心臟肌肉肌肢調節劑,用於肥厚型心肌病
Watching Shares Of Edgewise Therapeutics; Traders Circulating Undated Report; Edgewise Therapeutics Launches CIRRUS-HCM Trial To Assess Safety And Effects Of EDG-7500, A Novel Cardiac Sarcomere Modulator For Hypertrophic Cardiomyopathy
關注Edgewise Therapeutics股份;交易員傳播未經日期確認的報告;Edgewise Therapeutics啓動CIRRUS-HCm試驗,評估EDG-7500的安全性和作用,這是一種新型心臟肌肉肌功能調節劑,用於肥厚性心肌病。